SANUWAVE Health, Inc. (SNWV) stock
SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$1.70−0.11 (-6.08%)
Close on Nov 17, 2026Market cap $14.62MP/E –Yield –
SANUWAVE Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
SANUWAVE Health's ebitda for the twelve months ending Jun 30, 2026 was $2.61M, down 58.9% year over year. For fiscal 2025 it was $5.92M, up 27.7% from the year before. The highest annual figure on record is $5.92M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.92M | +27.7% |
| FY2024 | Dec 31, 2024 | $4.64M | +850.0% |
| FY2023 | Dec 31, 2023 | $488.00K | – |
| FY2022 | Dec 31, 2022 | -$8.00M | – |
| FY2021 | Dec 31, 2021 | -$12.91M | – |
| FY2020 | Dec 31, 2020 | -$24.90M | – |
| FY2019 | Dec 31, 2019 | -$8.72M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$29.00K | -101.8% |
| Q1 FY2026 | Mar 31, 2026 | -$830.00K | -202.5% |
| Q4 FY2025 | Dec 31, 2025 | $2.34M | +5.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.13M | -33.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.61M | -11.8% |
| Q1 FY2025 | Mar 31, 2025 | $810.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $2.23M | +73.3% |
| Q3 FY2024 | Sep 30, 2024 | $1.69M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.83M | +63.4% |
| Q1 FY2024 | Mar 31, 2024 | -$1.16M | – |
| Q4 FY2023 | Dec 31, 2023 | $1.29M | – |
| Q3 FY2023 | Sep 30, 2023 | -$344.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $1.12M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.72M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.19M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.30M | – |
| Q2 FY2022 | Jun 30, 2022 | -$2.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.77M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.10M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.30M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.66M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.04M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.21M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.74M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.50M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.01M | – |
See a number that looks wrong?